Announcement under Regulation 30 (LODR)-Change in Directorate
Globalspace Technologies Ltd operates in Healthcare Research, Analytics & Technology within the Healthcare sector.
1,771 historical price candles were omitted because the exchange source has not been verified.
No positive flags triggered.
Structured signal from quality, growth, valuation and momentum.
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Ratios derive from annual statements, which haven't been ingested yet.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
No scheme among the 32 fund houses on record reported a position in Globalspace Technologies Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
Documents link to external sources (exchange filings, company investor pages).
| Holder (%) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.31% | 55.88% | 55.88% | 55.86% | 55.84% | 55.84% | 55.27% | 55.84% | 55.84% | 55.84% | 55.84% | 55.84% | |
| 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.15% | |
| DII | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 44.69% | 44.12% | 44.12% | 44.14% | 44.16% | 44.16% | 44.73% | 44.16% | 44.16% | 44.16% | 44.16% | 44.01% | |
| No. of shareholders | — | — | — | — | — | — | — | 10,874 | 10,607 | 10,403 | 9,885 | 9,279 |
Promoter holding up 0.53 percentage points since Sep 2023.
| Person | Deal | Shares | Value | Holding | Filed |
|---|---|---|---|---|---|
| RAGAVAN RAJKUMARPromoters | PledgePledge Creation | 92,060 | ₹11.55 L | 18.70% → 18.70% | 14 Aug 20257(2) |
Disclosed under SEBI’s insider-trading regulations, which require a filing only above ₹10 lakh in a quarter — smaller dealings are in no disclosure. Holdings are the filer’s own percentages, not recomputed.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 24 Mar 2026 | VENU GOPAL PERURI | Bulk | NSE | Buy | 86,000 | ₹35.30 | ₹0.30 Cr |
| 23 Mar 2026 | VENU GOPAL PERURI | Bulk | NSE | Buy | 87,000 | ₹34.69 | ₹0.30 Cr |
| 16 Mar 2026 | VENU GOPAL PERURI | Bulk | NSE | Buy | 1,14,000 | ₹31.18 | ₹0.36 Cr |
| 12 Mar 2026 | VENU GOPAL PERURI | Bulk | NSE | Buy | 1,28,000 | ₹30.74 | ₹0.39 Cr |
| 9 Feb 2026 | VENU GOPAL PERURI | Bulk | NSE | Sell | 1,38,000 | ₹21.66 | ₹0.30 Cr |
| 9 Feb 2026 | ADITYA JALAN | Bulk | NSE | Buy | 80,000 | ₹21.65 | ₹0.17 Cr |
| 17 Apr 2025 | LAXMI VYANKATESH ENTERPRISES | Bulk | NSE | Sell | 1,10,000 | ₹13.94 | ₹0.15 Cr |
| 5 Mar 2025 | RAGAVAN RAJKUMAR | Bulk | NSE | Sell | 2,00,000 | ₹19.87 | ₹0.40 Cr |
| 5 Mar 2025 | LAXMI VYANKATESH ENTERPRISES | Bulk | NSE | Buy | 1,10,000 | ₹19.80 | ₹0.22 Cr |
| 21 Feb 2025 | DIPAKBHAI NANDLALBHAI VASVANI | Bulk | NSE | Buy | 82,000 | ₹24.65 | ₹0.20 Cr |
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Syngene International LimitedSYNGENESYNGENE | ₹14,586 Cr | ₹14,595 Cr | ₹3,600 Cr | ₹803 Cr | 24.6% | ₹221 Cr | 8.5% | 9.8% | 6.6% | -32 |
| Indegene LimitedINDGNINDGN | ₹14,303 Cr | ₹14,303 Cr | ₹3,813 Cr | ₹638 Cr | 17.6% | ₹401 Cr | 11.4% | 17.9% | 13.9% | 79 |
| Suven Life Sciences LimitedSUVENSUVEN | ₹8,139 Cr | ₹8,139 Cr | ₹9 Cr | ₹-366 Cr | — | ₹-352 Cr | — | -78.4% | -78.8% | 72 |
| Vimta Labs LimitedVIMTALABSVIMTALABS | ₹2,612 Cr | ₹2,631 Cr | ₹336 Cr | ₹112 Cr | 27.3% | ₹61 Cr | 12.9% | 17.4% | 13.6% | 179 |
| Bilcare LimitedBIBI | ₹227 Cr | ₹896 Cr | ₹788 Cr | ₹45 Cr | 5.7% | ₹-29 Cr | -7.1% | 1.5% | -6% | 78 |
| Take Solutions LimitedTAKETAKE | ₹187 Cr | ₹187 Cr | ₹85 Cr | ₹-2 Cr | -3.5% | ₹13 Cr | 20% | 18.5% | 42.1% | -7 |
| Jeevan Scientific Technology LtdJSTLJSTL | ₹169 Cr | ₹186 Cr | ₹62 Cr | ₹10 Cr | 16% | ₹0 Cr | 1.7% | 5.4% | 1.7% | -109 |
| Novelix Pharmaceuticals LtdNOVELIXNOVELIX | ₹167 Cr | ₹167 Cr | ₹9 Cr | ₹-3 Cr | -29.9% | ₹-2 Cr | -23.6% | -28.1% | -28.5% | 57 |
| Globalspace Technologies LtdGSTLGSTL | ₹103 Cr | — | ₹25 Cr | ₹11 Cr | 5.9% | ₹7 Cr | -1.4% | — | — | — |
| Adeshwar Meditex LtdADESHWARADESHWAR | ₹23 Cr | — | ₹56 Cr | ₹3 Cr | 4.9% | ₹1 Cr | 2.3% | — | — | — |
| Vanta Bioscience LtdVANTABIOVANTABIO | ₹15 Cr | — | ₹2 Cr | ₹1 Cr | 56.6% | ₹0 Cr | 6% | — | — | — |
Announcement under Regulation 30 (LODR)-Change in Management
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Shareholder Meeting / Postal Ballot-Outcome of AGM
Announcement under Regulation 30 (LODR)-Newspaper Publication
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Reg. 34 (1) Annual Report.
Notice Of The 16Th Annual General Meeting Of The Company For Financial Year 2025-26
| Date | Category | Subject | Filing |
|---|---|---|---|
| 1 Oct 2026, 12:08 pm | Company Update Change in Directorate | Announcement under Regulation 30 (LODR)-Change in Directorate | |
| 1 Oct 2026, 12:06 pm | Company Update Change in Management | Announcement under Regulation 30 (LODR)-Change in Management | |
| 1 Oct 2026, 11:47 am | AGM/EGM AGM | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | |
| 29 Sept 2026, 7:46 pm | AGM/EGM AGM | Shareholder Meeting / Postal Ballot-Outcome of AGM | |
| 6 Sept 2026, 5:03 pm | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication | |
| 5 Sept 2026, 6:42 pm | Company Update General | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | |
| 5 Sept 2026, 6:30 pm | Others Reg. 34 (1) Annual Report | Reg. 34 (1) Annual Report. | |
| 5 Sept 2026, 6:27 pm | AGM/EGM AGM | Notice Of The 16Th Annual General Meeting Of The Company For Financial Year 2025-26 |
Standalone figures · ₹ crore
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 25 | 9 | 19 | 29 | 17 | 21 | |
| COGS | 12 | 1 | 10 | 19 | 13 | 13 |
| Gross profit | 13 | 8 | 9 | 10 | 4 | 8 |
| 3 | 3 | 3 | 6 | 5 | 7 | |
| Operating profit (EBITDA) | 10 | 6 | 6 | 5 | -1 | 1 |
| OPM % | 38.9% | 62.4% | 31.7% | 16.5% | -6.9% | 5.9% |
| Depreciation | 2 | 4 | 4 | 3 | 1 | 1 |
| Interest | 1 | 1 | 2 | 2 | 1 | 1 |
| 0 | 0 | 0 | -4 | 0 | 0 | |
| Profit before tax | 7 | 0 | 1 | -4 | -3 | -0 |
| Tax | 1 | 0 | -0 | -0 | -0 | -0 |
| Tax % | 20.8% | 92.3% | -4% | -7.4% | -3% | -6.7% |
| 6 | 0 | 1 | -4 | -3 | -0 | |
| PAT margin % | 22.7% | 0.1% | 2.7% | -12.2% | -17% | -1.4% |
| EPS (₹) | 6.4 | — | — | — | -1.8 | -0.2 |
| EPS adjusted (₹) | 5 | 0 | 0.5 | -1 | — | — |
| 3.1% | — | — | — | — | — | |
| Annual report | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 11 | 11 | 11 | 34 | — | — |
| Reserves | 25 | 24 | 21 | 22 | — | — |
| 8 | 24 | 22 | 11 | — | — | |
| 7 | 5 | 4 | 3 | 61 | 71 | |
| Total equity & liabilities | 51 | 64 | 59 | 70 | 61 | 71 |
| 14 | 22 | 21 | 20 | 4 | 3 | |
| CWIP | — | — | — | — | — | — |
| Investments | 2 | 2 | 1 | 1 | 0 | 0 |
| 35 | 40 | 37 | 49 | 57 | 68 | |
| Total assets | 51 | 64 | 59 | 70 | 61 | 71 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 8 | -5 | 4 | -11 | -24 | 2 | |
| -8 | -12 | 0 | -4 | -0 | -0 | |
| 2 | 15 | -5 | 15 | 24 | -2 | |
| Net cash flow | 2 | -2 | 0 | 0 | 0 | -0 |
| Free cash flow | 0 | -17 | 4 | -15 | -24 | 2 |
| CFO / Operating profit % | 83.7% | -85.9% | 73.2% | -236.3% | — | 193.5% |